MAMATA CHAND – Rheumatology Physician, NPI 1275947467
Rheumatology Physician
Main info
Profile Insights
NPPES metrics only — not quality of care.
Provider Addresses for MAMATA CHAND
1635 N GEORGE MASON DR
ARLINGTON, VA 222053601
Phone: (703) 525-3069
Type: Location
2300 EYE STREET, NW
SUITE 718
WASHINGTON, DC 20037
Phone: (202) 741-2255
Type: Mailing
1221 MERCANTLE LANE
LARGO MEDICAL CENTER
UPPER MARLBORO, MD 20774
Phone: (301) 618-5500
Type: Location
3620 JOSEPH SIEWICK DR STE 306
FAIRFAX, VA 220331760
Phone: (410) 897-1941
Type: Location
166 DEFENSE HWY STE 200
ANNAPOLIS, MD 214018922
Phone: (410) 897-1941
Type: Mailing
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 233 Open Payments records for all available years, with a total value of $5,073.
Total Amount is formed as General ($5,073) + Research ($0) + Ownership ($0) = $5,073.
Last reported payment date: 2024-12-19 • Largest payer in this snapshot: ABBVIE INC. ($713).
Total Amount
$5,073
General + Research + Ownership
Payments
233
Total payment records
General Amount
$5,073
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-19
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| ABBVIE INC. | $713 |
| Amgen Inc. | $684 |
| Novartis Pharmaceuticals Corporation | $511 |
| ANI Pharmaceuticals, Inc. | $463 |
| Janssen Biotech, Inc. | $279 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2017-10-18
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20171018002065 | I | Rheumatology | DC | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 23,200 | 14 | $0 |
| J0897 | Injection, denosumab, 1 mg | 2,040 | 24 | $0 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 185 | 89 | $0 |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 156 | 43 | $0 |
| 96375 | Injection of additional new drug or substance into vein | 86 | 15 | $0 |
Insurance plans in this area (ZIP 22205)
Loading plans...
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.